- Home
- YMAB vs LFVN Comparison
YMAB vs LFVN Comparison
Compare YMAB & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- LFVN
- Stock Information
- Founded
- YMAB 2015
- LFVN N/A
- Country
- YMAB United States
- LFVN United States
- Employees
- YMAB N/A
- LFVN N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- LFVN Biotechnology: Pharmaceutical Preparations
- Sector
- YMAB Health Care
- LFVN Health Care
- Exchange
- YMAB Nasdaq
- LFVN Nasdaq
- Market Cap
- YMAB 192.4M
- LFVN 165.9M
- IPO Year
- YMAB 2018
- LFVN N/A
- Fundamental
- Price
- YMAB $4.36
- LFVN $12.01
- Analyst Decision
- YMAB Buy
- LFVN Strong Buy
- Analyst Count
- YMAB 11
- LFVN 2
- Target Price
- YMAB $17.55
- LFVN $30.50
- AVG Volume (30 Days)
- YMAB 202.0K
- LFVN 180.7K
- Earning Date
- YMAB 08-11-2025
- LFVN 08-27-2025
- Dividend Yield
- YMAB N/A
- LFVN 1.35%
- EPS Growth
- YMAB N/A
- LFVN 152.87
- EPS
- YMAB N/A
- LFVN 0.70
- Revenue
- YMAB $88,658,000.00
- LFVN $222,347,000.00
- Revenue This Year
- YMAB N/A
- LFVN $17.36
- Revenue Next Year
- YMAB $15.15
- LFVN $9.60
- P/E Ratio
- YMAB N/A
- LFVN $16.87
- Revenue Growth
- YMAB 4.92
- LFVN 8.22
- 52 Week Low
- YMAB $3.55
- LFVN $5.76
- 52 Week High
- YMAB $16.11
- LFVN $27.38
- Technical
- Relative Strength Index (RSI)
- YMAB 45.29
- LFVN 40.54
- Support Level
- YMAB $4.10
- LFVN $12.94
- Resistance Level
- YMAB $4.62
- LFVN $14.62
- Average True Range (ATR)
- YMAB 0.29
- LFVN 0.75
- MACD
- YMAB -0.04
- LFVN -0.06
- Stochastic Oscillator
- YMAB 20.73
- LFVN 16.37
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.